Hypo-G01 study presented at the ESMO 2024
Thursday, 26 September 2024
Dr Sofia Rivera from the Gustave Roussy Institute presented the results of the Hypo-G01 study in France at ESMO 2024. This study is one of three that form the basis of the database on which PRE-ACT Horizons is built.
Prediction of radiotherapy side effects using explainable AI
Over the next 3 years, the PRE-ACT consortium will predict the risk of radiotherapy side effects, including arm lymphedema in breast cancer patients, using Explainable Artificial Intelligence (AI), resulting in a personalised app for doctors and patients.
See the explanation of the study on YouTube (in French). Click below.